L’Oréal’s US subsidiary has agreed to a settlement in a lawsuit which claimed that chemicals in hair relaxer products contributed to the development of cancer.
In a statement provided to Cosmetics Business, a L’Oréal USA spokesperson said: “Our highest priority is the health and wellbeing of all our consumers.
“Our products are subject to a rigorous scientific evaluation of their safety by experts who also ensure that we strictly follow all regulations in every market in which we operate.
“We stand by the safety of SoftSheen-Carson's products.”
The four plaintiffs in the case had claimed that the use of chemical hair relaxers contributed to their development of gynaecological cancers.
The lawsuit was the first to reach trial in the US related to allegations of cancer risks associated with hair relaxer products.